Literature DB >> 23214446

Production of glycosylated soluble amyloid precursor protein alpha (sAPPalpha) in Leishmania tarentolae.

Stephan Klatt1, Michael Rohe, Kathirvel Alagesan, Daniel Kolarich, Zoltán Konthur, Daniela Hartl.   

Abstract

Soluble amyloid precursor protein alpha (sAPPalpha) is a cleavage product of the amyloid precursor protein (APP), the etiologic agent in Alzheimer's disease (AD). Reduced expression of sAPPalpha was previously found in the brains of AD patients, and it was suggested that sAPPalpha might counteract neurotoxic effects of Abeta, another APP cleavage product with enhanced abundance in Alzheimer's diseased brains. However, little is known about the biological functions of sAPPalpha. Thus, efficient production of this protein is a prerequisite for further studies. The unicellular eukaryotic parasite Leishmania tarentolae has recently emerged as a promising expression system for eukaryotic proteins due to its ability to posttranslationally modify proteins combined with easy cultivation and high protein yield. Interestingly, sAPPalpha produced in L. tarentolae was biologically active and glycosylated. In contrast to nonglycosylated sAPPalpha expressed in Eschericha coli, it also featured higher stability against enzymatic degradation. Detailed analysis of the glycosylation pattern of sAPPalpha produced in L. tarentolae by PGC-LC-ESI-MS/MS N-glycan analysis identified among eukaryotic species the highly conserved core pentasaccharide (Man3GlcNAc2) as being attached to Asn467 of sAPPalpha. Using oxonium ion scanning of CID-MS/MS spectra in combination with ETD fragmentation, we also identified two peptides (peptides 269-288 and 575-587) modified with N-acetyl hexosamine (HexNAc) residues. One of these O-glycosylation sites could be unambiguously assigned to Thr576 of sAPPalpha. This is the first time that O-glycosylation of a recombinant protein expressed in L. tarentolae has been demonstrated. Together, human sAPPalpha produced in L. tarentolae was N- and O-glycosylated on similar sites as described for mammalian-expressed sAPPalpha and showed similar biological activity. This demonstrates that L. tarentolae is a very suitable and simple to handle expression system for mammalian glycoproteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23214446     DOI: 10.1021/pr300693f

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  10 in total

1.  Glycoproteins Enrichment and LC-MS/MS Glycoproteomics in Central Nervous System Applications.

Authors:  Rui Zhu; Ehwang Song; Ahmed Hussein; Firas H Kobeissy; Yehia Mechref
Journal:  Methods Mol Biol       Date:  2017

Review 2.  Humanizing glycosylation pathways in eukaryotic expression systems.

Authors:  Amjad Hayat Khan; Hadi Bayat; Masoumeh Rajabibazl; Suriana Sabri; Azam Rahimpour
Journal:  World J Microbiol Biotechnol       Date:  2016-11-11       Impact factor: 3.312

3.  Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infections.

Authors:  Joshua D Jones
Journal:  Infect Dis Poverty       Date:  2015-04-01       Impact factor: 4.520

4.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

Review 5.  Leishmania tarentolae: Taxonomic classification and its application as a promising biotechnological expression host.

Authors:  Stephan Klatt; Larry Simpson; Dmitri A Maslov; Zoltán Konthur
Journal:  PLoS Negl Trop Dis       Date:  2019-07-25

6.  Epidemic Preparedness-Leishmania tarentolae as an Easy-to-Handle Tool to Produce Antigens for Viral Diagnosis: Application to COVID-19.

Authors:  Ilaria Varotto-Boccazzi; Alessandro Manenti; Francesca Dapporto; Louise J Gourlay; Beatrice Bisaglia; Paolo Gabrieli; Federico Forneris; Silvia Faravelli; Valentina Bollati; Diego Rubolini; Gianvincenzo Zuccotti; Emanuele Montomoli; Sara Epis; Claudio Bandi
Journal:  Front Microbiol       Date:  2021-12-13       Impact factor: 5.640

7.  Soluble alpha-APP (sAPPalpha) regulates CDK5 expression and activity in neurons.

Authors:  Daniela Hartl; Stephan Klatt; Manfred Roch; Zoltan Konthur; Joachim Klose; Thomas E Willnow; Michael Rohe
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

8.  Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae.

Authors:  Mathias Lindh Jørgensen; Niels Anton Friis; Jesper Just; Peder Madsen; Steen Vang Petersen; Peter Kristensen
Journal:  Microb Cell Fact       Date:  2014-01-15       Impact factor: 5.328

9.  Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.

Authors:  Anna Czarnota; Jolanta Tyborowska; Grażyna Peszyńska-Sularz; Beata Gromadzka; Krystyna Bieńkowska-Szewczyk; Katarzyna Grzyb
Journal:  Microb Cell Fact       Date:  2016-04-13       Impact factor: 5.328

10.  Glycosylation of Trypanosoma cruzi TcI antigen reveals recognition by chagasic sera.

Authors:  Niamh Murphy; Barrie Rooney; Tapan Bhattacharyya; Omar Triana-Chavez; Anja Krueger; Stuart M Haslam; Victoria O'Rourke; Magdalena Pańczuk; Jemima Tsang; Jack Bickford-Smith; Robert H Gilman; Kevin Tetteh; Chris Drakeley; C Mark Smales; Michael A Miles
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.